|
Study of Fluoxetine in Adults With Autistic Disorder Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for qualified medical advice, visits or professional assistance by using a real mD. We are not docs. Always confer with your physician about Study of Fluoxetine in Adults With Autistic Disorder conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Study of Fluoxetine in Adults With Autistic Disorder Clinical research trials and Study of Fluoxetine in Adults With Autistic Disorder health trials occur in many of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectivity of new does drugs. The intent of the studies / undertakings is to resolve particular human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to detect remedies for all sorts of conditions, including Study of Fluoxetine in Adults With Autistic Disorder. Study of Fluoxetine in Adults With Autistic Disorder Clinical Trials and other clinical trials permit volunteers to obtain healthcare treatment alternatives before they are available to the masses. Most times the participants undergo professional assistance for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Study of Fluoxetine in Adults With Autistic Disorder clinical trial. Test subjects typically receive the most expert healthcare available for their Study of Fluoxetine in Adults With Autistic Disorder condition. Dangers are a reality, however, and may include more or frequent mD visits, healthcare dangers (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study of Fluoxetine in Adults With Autistic Disorder  Study of Fluoxetine in Adults With Autistic Disorder
Study of Fluoxetine in Adults With Autistic Disorder
For Condition: Autistic Disorder
Status: Recruiting
Sponsor(s): FDA Office of Orphan Products Development ,
Synopsis: This is a study to determine the effect of fluoxetine in the treatment of adult autism and on functional ability and behavior associated with autism. Evidence suggests abnormal serotonin function in autism. Fluoxetine is a selective inhibitor of the serotonin transporter.
Details: Eligible patients will undergo comprehensive evaluation. Informants familiar with the patient will also provide information. Patients will be randomized to receive treatment or placebo. During the 12-week treatment there will be weekly monitoring for the first 4 weeks and biweekly monitoring for the next 8 weeks. The drug dosage will be increased each week as tolerated by the patient. Serum levels of fluoxetine and norfluoxetine will be documented at Week 12.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Both
Protocol Entry Criteria: Inclusion criteria: - Meets DSM-IV and ADI criteria for autistic disorder - Patients must use effective contraception - Negative pregnancy test - Clinical Global Impression-Severity Scale for Autistic Disorder (CGI-AD) score of 4 Exclusion criteria: - Pregnant or nursing - Prior or concurrent history of mental disorders, including schizophrenia, schizoaffective disorder, organic mental disorders, or bipolar disorders - Concurrent depression determined by DSM-IV diagnosis - Serious suicidal risk - Active seizure disorder within the past 2 years - Clinically significant or unstable medical illness, including hematopoietic or cardiovascular disease - Any organic or systemic disease - Any geographical condition that would preclude study compliance - Prior or concurrent gastrointestinal, liver, or kidney disease - Any other concurrent condition that interferes with the absorption, distribution, metabolism, or excretion of drugs - Prior or concurrent cerebrovascular disease or brain trauma - Prior or concurrent clinically significant unstable endocrine disorder, such as hypo- or hyperthyroidism - Prior or concurrent malignancy - Clinically significant abnormalities on EKG, laboratory tests, or physical exam - Requirement for ECT or any other psychotropic medication - Inability to tolerate taper from psychoactive medication - History of hypersensitivity or severe side effects associated with the use of fluoxitine or other serotonin reuptake inhibitors - Treatment with any drug known to have a well-defined potential for toxicity to a major organ within the past 30 days - Concurrent terfenadine (Seldane) or astemizole (Hismanal) - Prior treatment with fluoxetine of 40 mg/day for 6 weeks - Prior electroconvulsive therapy within the past 3 months - Prior investigational drug use within the past 30 days - Prior Monoamine oxidase inhibitor use within the past 14 days - Prior long-acting phenothiazines within the past 6 weeks - Prior psychotropic drugs within the past 7 days - Prior fluoxetine within the past 6 weeks - Requirement for any therapeutic intervention that would confound study evaluation
Total Enrollment: 50
Location and Contact Information:
Overall Study Official:
EricHollander, Principal Investigator, Mount Sinai School of Medicine New York, New York, United States
Mount Sinai School of Medicine *Recruiting*
New York City, New York, 10029
United States
Recruiting Karen Zagursky 212-241-7098
Additional Information:
Study ID Numbers: FD-R-2026-01; FD-R-002026-01
Study Start Date: September 2001
Record last reviewed: November 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00027404
Other Autistic Disorder Studies:
1. Treatment of Autism in Children and Adolescents
2. Study of Fluoxetine in Adults With Autistic Disorder
3. A Controlled Study of Olanzapine in Children with Autism
4. Drug Treatment for Autism
5. RUPP PI PDD: Drug and Behavioral Therapy for Children with Pervasive Developmental Disorders
Related Studies:
Other Autistic Disorder Clinical Trials
Other New York Clinical Trials
Other New York City Clinical Trials
Study of Fluoxetine in Adults With Autistic Disorder
|
|
|
|
|
|
|
|
